Bexion Pharmaceuticals, Inc.
6 clinical trials · Sponsor
◉ Watch Bexion Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| BXQ-350 in Newly Diagnosed Metastatic Colorectal Carcinoma (NCT05322590) | Bexion Pharmaceuticals, Inc. | 2023-01-09 |
| BXQ-350 Pharmacokinetic/Pharmacodynamic Study in Cancer Patients (NCT05291286) | Bexion Pharmaceuticals, Inc. | 2022-10-17 |
| A Study of BXQ-350 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) or Diffuse Midline Glioma (DMG) (NCT04771897) | Bexion Pharmaceuticals, Inc. | 2021-05-24 |
| Continued Treatment for Participants Enrolled in Studies of BXQ-350 (NCT04404569) | Bexion Pharmaceuticals, Inc. | 2020-06-08 |
| A Study of BXQ-350 in Children and Young Adults With Relapsed Solid Tumors (NCT03967093) | Bexion Pharmaceuticals, Inc. | 2019-04-15 |
Track Bexion Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.